NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
06/05/2025
Back to search
Official data from USPTO
BIOPHARMASPEC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIOPHARMASPEC
ST13
US500000079154693Class
41, 42
Filing
79154693
Registration
4801698
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
06/05/2025
Trademark type
Word
Nice classes
41, 42
Filing date
04/22/2014
Registration date
09/01/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/05/2025
Last transaction
06/05/2025
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
JERSEY, GB
Examiner
LEE, YATSYE ISADORA
Current location
Historical data usage
Holders and representatives
Holders
Biopharmaspec Limited
Biopharmaspec Limited
Representatives
Hara K. Jacobs Ballard Spahr LLP
Technical classification
Nice Classes
Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Educationaltraining and instructional services in the nature of coursesseminarstutorialsconferences and workshops in the field of scientific research and analysis; providing education and training servicestraining coursesseminarstutorialsconferences and workshops on scientific analysis and analytical techniques; production of sound and video recordings in the field of scientific research and analysis for training purposes; publication of training manuals and educationalinstructional and teaching materials; publication of scientific reports and texts; providing online electronic publicationselectronic books and journals in the field of scientific research and analysis; informationadvisory and consultancy services relating to all of the aforesaid services
Class 42
Scientific research and development services; scientific analytical serviceschemical and biochemical analysis services for scientific research purposes; scientific analysis of materials and substances; development of scientific analytical methods; pharmaceuticalbiopharmaceutical and biotechnological discoveryresearch and development services; pharmacokinetics research and development services; pre-clinical analytical testing services; laboratory services for analytical testing; bacteria testing and analysis services; sample testing and analysis services; mass spectrometry services; chromatography services; protein and glycoprotein analysis and sequencing; carbohydrate analysis and sequencing; gas phase sequencing; gel electrophoresis analysis; SEC MALLS analysis Size Exclusion Chromatography (SEC) with Multi-Angle Laser-Light Scattering-protein aggregation analysis; amino acid and sugar composition analysis; protein aggregation analysis; scientific research involving structural characterization of biopolymerssmall molecule drugs and metabolites; compilation and provision of scientific data in the field of chemistry and biochemistry for research purposes; scientific data interpretation servicesscientific analysis in the field of chemistry and biochemistry; preparation and provision of scientific reportsproviding scientific information in the fields of chemistry and biochemistry; provision of certificates of analysisfor the purpose of certifying the results of scientific analysis; design of computer software or computer programs for scientific or analytical applications; providing temporary use of on-linenon-downloadable software for automated presentation and interpretation of scientific data; informationadvisory and consultancy services relating to all of the aforesaid services
Publications
History of USPTO decisions and trademark events.
39 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
06/05/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/02/2025
ES71
TEAS SECTION 71 RECEIVED
02/11/2025
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
09/01/2024
RNWL
INTERNATIONAL REGISTRATION RENEWED
02/23/2024
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
02/07/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/07/2022
PRAN
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
02/07/2022
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
02/07/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/02/2022
ES75
TEAS SECTION 71 & 15 RECEIVED
07/20/2021
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/01/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/03/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/13/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/27/2016
FIMP
FINAL DISPOSITION PROCESSED
01/27/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/01/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
09/01/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/16/2015
PUBO
PUBLISHED FOR OPPOSITION
06/16/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/27/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/12/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/12/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/15/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/15/2015
ALIE
ASSIGNED TO LIE
04/14/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/09/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/02/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/02/2015
RFNT
REFUSAL PROCESSED BY IB
12/12/2014
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/24/2014
RFRR
REFUSAL PROCESSED BY MPU
11/24/2014
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/21/2014
CNRT
NON-FINAL ACTION WRITTEN
11/20/2014
MAFR
APPLICATION FILING RECEIPT MAILED
11/18/2014
DOCK
ASSIGNED TO EXAMINER
11/14/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/14/2014
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/13/2014
Continuous trademark protection
Get notified about every new filing that threatens BIOPHARMASPEC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.